WRBC
CHAQ.WS

W.R. Berkley Corp’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

W.R. Berkley Corp’s Portfolio CHAQ.WS Stock Details CHAQ.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-73,907
Closed -$51K – 160
2020
Q2 		$51K Buy
+73,907
New +$50.1K 0.01% 96

Other funds holding CHAQ.WS

BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

W.R. Berkley Corp's CHAQ.WS Position: Q3 2020 in Review

W.R. Berkley Corp sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2020, closing a stake of 73,907 shares — an estimated $51K sold.

W.R. Berkley Corp first reported a position in CHAQ.WS in Q2 2020 and held it in 1 quarter. The position peaked at $51K in Q2 2020. 13 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2020.

  • W.R. Berkley Corp reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2020 after selling out during the quarter.
  • W.R. Berkley Corp sold 73,907 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2020, an estimated $51K.
  • W.R. Berkley Corp first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q2 2020 and held it in 1 quarter.
  • W.R. Berkley Corp's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $51K in Q2 2020.
  • 13 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2020.

Based on W.R. Berkley Corp's 13F filing for Q3 2020, filed 16 Nov 2020.